Paul Kornblith, M.D.
Medical Adviser to Helomics
Paul Kornblith, M.D., currently serves as the Medical Advisor to Helomics, the Pittsburgh Life Sciences Greenhouse, and the Innovation Institute; as an Adjunct Professor in the School of Health and Rehabilitation at the University of Pittsburgh; and as the Western Pennsylvania Director for Life Sciences PA. A world-renown neurosurgeon, clinician, and clinical cancer researcher, Dr. Kornblith has authored over 150 peer-reviewed publications, 30 textbook chapters, and four textbooks. Dr. Kornblith also served as Vice Chairman of the Department of Neurosurgery at the University of Pittsburgh Medical School and the University of Pittsburgh Medical Center; Professor and Chairman of the Department of Neurosurgery at the Albert Einstein College of Medicine and Montefiore Hospital in New York; Chief of the Surgical Neurology Branch and Interim Clinical Director of the Neurological Institute at the National Institutes of Health in Bethesda, MD; Assistant Professor of Surgery and Director of the Cancer Program Project in the Department of Neurosurgery at Harvard University, and as an Attending Neurosurgeon at the Massachusetts General Hospital in Boston; and Editor-and-Chief of the Journal of Neuro-Oncology. Dr. Kornblith received his B.A. degree from Temple University and his M.D degree from Thomas Jefferson Medical School.
Amelia Wall Warner, PharmD, RPh
Founder and CEO of Global Specimen Solutions, Inc.
Dr. Amelia Warner founded Global Specimen Solutions, Inc. in 2013 with the vision of radically improving translational science through powerful new pipeline data management analytics. Prior to GSS, Amelia served as CEO, President and Director of the Board for Gentris Corporation, where she led a financial and operational turnaround resulting in the successful sale of Gentris to a public company. Amelia served as the Head of Clinical Pharmacogenomics and Clinical Specimen Management for Merck Research Laboratories (MRL). She oversaw all clinical pharmacogenomics projects, as well as policies and procedures for biosample collection and storage for clinical trial samples; she also served as the MRL Pharmacogenomics Expert for the Translational Science Research Network. She was the MRL Key Expert for Global Regulation for Genetic Research and Human Specimen Usage Regulation/Law. She served as Chair of the Industry Pharmacogenomics Working Group (I-PWG) and a PhRMA Representative to ICH E16- Genomic Biomarkers Related to Drug Response.
Amelia completed a Residency in Pediatric Pharmacotherapy at St. Jude Children’s Research Hospital and a Fellowship in Clinical Pharmacology/Pharmacogenomics at St. Jude Children’s Research Hospital with William Evans, PharmD. Amelia holds a BS in Biology from Wake Forest University and a PharmD from the University of North Carolina at Chapel Hill.
Mark Malandro, Ph.D, CLP, RTTP
Vice President of Operations for Sciences, Chan Zuckerberg Science Initiative
Marc Malandro PhD, CLP, RTTP is currently Vice President of Operations for Science at the Chan Zuckerberg Initiative. Dr. Malandro was the founding director of the Innovation Institute and Vice Chancellor for Technology Management and Commercialization at the University of Pittsburgh. Dr. Malandro was responsible for leading the combination of the Office of Technology Management, the Office of Enterprise Development and the Institute for Entrepreneurial Excellence forming the Pitt Innovation Institute in 2013. Prior to The University of Pittsburgh, Dr. Malandro, who has a doctoral degree in biochemistry and molecular biology from the University of Florida, co-founded Sagres Discovery, a California-based systems biology company focused on the understanding of the molecular basis of cancer.
Prof. Robert Murphy, Ph.D
Head, Computational Biology Department Carnegie Mellon University
Robert F. Murphy is the Ray and Stephanie Lane Professor of Computational Biology and Head of the Computational Biology Department (formerly the Ray and Stephanie Lane Center for Computational Biology) in the School of Computer Science at Carnegie Mellon University. He also is Professor of Biological Sciences, Biomedical Engineering, and Machine Learning, and was a founding director (with Ivet Bahar) of the Joint Carnegie Mellon University-University of Pittsburgh Ph.D. Program in Computational Biology. He is also Honorary Professor of Biology at the Albert Ludwig University of Freiburg, Germany, was named as the first External Senior Fellow of the School of Life Sciences in the Freiburg Institute for Advanced Studies, and was the recipient of an Alexander von Humboldt Foundation Senior Research Award. He is a Fellow of the American Institute for Medical and Biological Engineering and served as President of the International Society for Advancement of Cytometry. He was the first full-term chair of the Biodata Management and Analysis Study Section of the National Institutes of Health, and was a member of the National Advisory General Medical Sciences Council, and the National Institutes of Health Council of Councils.
Dr. Murphy has received research grants from the National Institutes of Health, the National Science Foundation, the American Cancer Society, the American Heart Association, the Arthritis Foundation, and the Rockefeller Brothers Fund. He has co-edited two books and three special journal issues on cell imaging, and has published over 200 research papers. Dr. Murphy received an A.B. in Biochemistry from Columbia College and a Ph.D. in Biochemistry from the California Institute of Technology.